These findings indicate a significant overlap between the circulating SASP signature induced by GCR exposure in mice and the proteomic profiles of human breast and CRC tumors, suggesting that GCR-induced systemic SASP factors may contribute to tumor development in these human cancers. This evidence concerns the gene NR3C1 and cancer.